The phototherapy treatment market is projected to be valued at US$ 1,948.90 million in 2023. The market research report anticipates a valuation of US$ 3,230.90 million by 2033. The phototherapy treatment market is expected to record a CAGR of 5.20% during the forecast period.
Phototherapy Treatment Market Trends and Highlights
| Attributes | Key Insights |
|---|---|
| Market Estimated Size in 2023 | US$ 1,948.90 million |
| Projected Market Value in 2033 | US$ 3,230.90 million |
| Value-based CAGR from 2023 to 2033 | 5.20% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Skin diseases are among the most common of all human health afflictions and affect almost 900 million people in the world at any time. Five common conditions account for over 80% of all skin diseases. These may cause rashes, inflammation, itchiness, or other skin changes. Some skin conditions may be genetic, while lifestyle factors may cause others. Skin disease treatment may include medications, creams, ointments, or lifestyle changes.
Phototherapy has emerged as a highly effective approach to addressing many skin problems in recent years. Phototherapy uses light waves to treat certain skin conditions. The skin is exposed to ultraviolet (UV) light for a set amount of time. Phototherapy uses a man-made source of UV light. UV light also comes from the sun. When combined with a medication called psoralen, the procedure is known as psoralen UVA (PUVA).
UV light shuts down immune system cells in the skin. It can help in skin conditions caused by an immune system overreaction. Some conditions that can be cured using this approach include psoriasis, eczema, mycosis fungoides, and vitiligo, among others. As awareness of phototherapy's benefits in treating acne grows among patients and healthcare providers, more individuals are seeking this form of treatment.
| Market Value in 2022 | 1,838.10 million |
|---|---|
| Market Value in 2033 | 3,230.90 million |
Principal Consultant
Forecast CAGRs from 2023 to 2033
| The United States | 2.30% |
|---|---|
| Germany | 3.10% |
| India | 7.80% |
| China | 6.70% |
The phototherapy treatment market in the United States has been steadily growing, driven by factors such as the increasing prevalence of skin disorders like psoriasis and eczema. The market has benefited from advancements in technology and a growing acceptance of phototherapy as an effective treatment option
The phototherapy market in the United States is well-developed and advanced, with a high prevalence of skin disorders. Technological advancements and a strong regulatory framework contribute to market growth. Accessibility to phototherapy services is relatively good, particularly in urban areas.
The growing population of adult women suffering from acne and psoriasis is an important factor driving revenue growth of the phototherapy segment. The population of adult women is rising at higher rates in the United States. United States is to account for a CAGR of 2.30% by the end of 2023
Germany is a major player in the European phototherapy market. The country has a strong focus on healthcare technology and innovation, leading to advancements in phototherapy equipment. High healthcare standards and insurance coverage support the market. Germany is to account for a CAGR of 3.10% by the end of 2023
The market benefits from ongoing research and development in dermatology and a well-regulated healthcare system with access to phototherapy treatments for various skin disorders. The presence of a substantial aging population contributes to the demand for dermatological treatments.
China is to account for a CAGR of 6.70% by the end of 2023. The phototherapy treatment market in China has been growing rapidly alongside the expansion of healthcare infrastructure. A large population and increasing awareness of dermatological treatments drive the market. The country's emerging middle class seeks access to advanced healthcare services. The market benefits from a strong emphasis on cosmetic dermatology and skin conditions.
Rising awareness of modern phototherapy, high per-capita disposable income, and the expansion of healthcare infrastructure is boosting phototherapy treatment in China. Growth in the percentage of newborns in China, an increase in the prevalence of neonatal jaundice, and the necessity for cost-effective treatment are all expected to fuel the market growth in China.
India is likely to closely follow China in the adoption of phototherapy treatment owing to its huge population base in the country. Regulatory reforms, favorable government policies, and improved healthcare infrastructure are expected to influence present and future market trends positively. India is to account for a CAGR of 7.80% by the end of 2023
The phototherapy market in India is growing due to the rising prevalence of skin disorders and increased healthcare spending. Phototherapy is available in major cities and urban centers, and the market is expanding to smaller towns and rural areas.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Category | Market Share |
|---|---|
| Blue Light Therapy | 42.20% |
| Acne | 60.40% |
By phototherapy type, blue light therapy dominated the phototherapy treatment market for psoriasis and acne and is expected to be the most lucrative segment over the forecast period, with a market share of 42.20%.
Blue light therapy has been found to be effective in treating specific skin conditions, such as acne and actinic keratosis. It's particularly beneficial for those who have not responded well to other treatments. Blue light therapy can reduce the number of acne lesions and improve the appearance of the skin. Blue light therapy is a non-invasive and pain-free treatment. Patients do not experience discomfort during the procedure, making it more attractive, especially to those who are sensitive to pain or prefer non-surgical options.
Blue light therapy typically has minimal side effects. Patients may experience mild redness or temporary skin dryness, but these side effects are generally well-tolerated and short-lived.
The acne segment is expected to be the largest contributor to the market based on disease type. The acne segment is expected to account for a 60.4% share of the phototherapy treatment market in 2023.
Acne is one of the most common skin conditions globally, affecting a significant portion of the population, particularly adolescents and young adults. This widespread prevalence ensures a continuous demand for effective acne treatments.
Phototherapy, including blue light therapy and red light therapy, has demonstrated its efficacy in treating acne. These treatments can reduce the number of acne lesions, minimize inflammation, and improve the skin's overall appearance.
Companies indulged in developing phototherapy treatment therapies are actively seeking to strengthen their position through approval and agreements with established healthcare institutes. Collaborations, mergers & acquisition partnerships with regional players can accelerate their strategy to capture a significant share of the emerging markets.
Some of the developments by players in the phototherapy treatment market are given below-
| Attributes | Details |
|---|---|
| Estimated Market Size in 2023 | US$ 1,948.90 million |
| Projected Market Valuation in 2033 | US$ 3,230.90 million |
| Value-based CAGR 2023 to 2033 | 5.20% |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | Value in US$ million |
| Key Regions Covered |
|
| Key Market Segments Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
The phototherapy treatment market is expected to reach US$1,948.90 million in 2023.
The phototherapy treatment market is set to expand by a CAGR of 5.20% by 2033.
The phototherapy treatment market is forecast to reach US$ 3,230.90 million by 2033.
A significant share of profits will likely come from the Industry in North America.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Disease Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Disease Type, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Disease Type, 2023 to 2033
5.3.1. Psoriasis
5.3.1.1. Guttate Psoriasis
5.3.1.2. Inverse Psoriasis
5.3.1.3. Pustular Psoriasis
5.3.1.4. Erythrodermic Psoriasis
5.3.1.5. Plaque Psoriasis
5.3.2. Acne
5.3.2.1. Acne Vulgaris
5.3.2.2. Acne Conglobate
5.3.2.3. Acne Fulminans
5.3.2.4. Gram-Negative Folliculitis
5.3.2.5. Acne Rosacea
5.3.2.6. Pyoderma Faciale
5.4. Y-o-Y Growth Trend Analysis By Disease Type, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Disease Type, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Phototherapy Type
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Phototherapy Type, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Phototherapy Type, 2023 to 2033
6.3.1. Blue Light Phototherapy
6.3.2. Red Light Phototherapy
6.3.3. Intense Pulsed Light (IPL) Phototherapy
6.3.4. Narrowband UVB Phototherapy
6.3.5. Psoralens+Ultravioletlight A (PUVA) Phototherapy
6.4. Y-o-Y Growth Trend Analysis By Phototherapy Type, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Phototherapy Type, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) Analysis By End User , 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By End User , 2023 to 2033
7.3.1. Hospitals
7.3.2. Dermatology Clinics/Skin Care Centres
7.3.3. Wellness Centres
7.3.4. Home Care Settings
7.4. Y-o-Y Growth Trend Analysis By End User , 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End User , 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Western Europe
8.3.4. Eastern Europe
8.3.5. South Asia and Pacific
8.3.6. East Asia
8.3.7. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Disease Type
9.2.3. By Phototherapy Type
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Disease Type
9.3.3. By Phototherapy Type
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Disease Type
10.2.3. By Phototherapy Type
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Disease Type
10.3.3. By Phototherapy Type
10.3.4. By End User
10.4. Key Takeaways
11. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. UK
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Western Europe
11.2.2. By Disease Type
11.2.3. By Phototherapy Type
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Disease Type
11.3.3. By Phototherapy Type
11.3.4. By End User
11.4. Key Takeaways
12. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. Poland
12.2.1.2. Russia
12.2.1.3. Czech Republic
12.2.1.4. Romania
12.2.1.5. Rest of Eastern Europe
12.2.2. By Disease Type
12.2.3. By Phototherapy Type
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Disease Type
12.3.3. By Phototherapy Type
12.3.4. By End User
12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. India
13.2.1.2. Bangladesh
13.2.1.3. Australia
13.2.1.4. New Zealand
13.2.1.5. Rest of South Asia and Pacific
13.2.2. By Disease Type
13.2.3. By Phototherapy Type
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Disease Type
13.3.3. By Phototherapy Type
13.3.4. By End User
13.4. Key Takeaways
14. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
14.2.1. By Country
14.2.1.1. China
14.2.1.2. Japan
14.2.1.3. South Korea
14.2.2. By Disease Type
14.2.3. By Phototherapy Type
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Disease Type
14.3.3. By Phototherapy Type
14.3.4. By End User
14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Disease Type
15.2.3. By Phototherapy Type
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Disease Type
15.3.3. By Phototherapy Type
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2022
16.1.2.1. By Disease Type
16.1.2.2. By Phototherapy Type
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2022
16.2.2.1. By Disease Type
16.2.2.2. By Phototherapy Type
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2022
16.3.2.1. By Disease Type
16.3.2.2. By Phototherapy Type
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2022
16.4.2.1. By Disease Type
16.4.2.2. By Phototherapy Type
16.4.2.3. By End User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2022
16.5.2.1. By Disease Type
16.5.2.2. By Phototherapy Type
16.5.2.3. By End User
16.6. UK
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2022
16.6.2.1. By Disease Type
16.6.2.2. By Phototherapy Type
16.6.2.3. By End User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2022
16.7.2.1. By Disease Type
16.7.2.2. By Phototherapy Type
16.7.2.3. By End User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2022
16.8.2.1. By Disease Type
16.8.2.2. By Phototherapy Type
16.8.2.3. By End User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2022
16.9.2.1. By Disease Type
16.9.2.2. By Phototherapy Type
16.9.2.3. By End User
16.10. Poland
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2022
16.10.2.1. By Disease Type
16.10.2.2. By Phototherapy Type
16.10.2.3. By End User
16.11. Russia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2022
16.11.2.1. By Disease Type
16.11.2.2. By Phototherapy Type
16.11.2.3. By End User
16.12. Czech Republic
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2022
16.12.2.1. By Disease Type
16.12.2.2. By Phototherapy Type
16.12.2.3. By End User
16.13. Romania
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2022
16.13.2.1. By Disease Type
16.13.2.2. By Phototherapy Type
16.13.2.3. By End User
16.14. India
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2022
16.14.2.1. By Disease Type
16.14.2.2. By Phototherapy Type
16.14.2.3. By End User
16.15. Bangladesh
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2022
16.15.2.1. By Disease Type
16.15.2.2. By Phototherapy Type
16.15.2.3. By End User
16.16. Australia
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2022
16.16.2.1. By Disease Type
16.16.2.2. By Phototherapy Type
16.16.2.3. By End User
16.17. New Zealand
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2022
16.17.2.1. By Disease Type
16.17.2.2. By Phototherapy Type
16.17.2.3. By End User
16.18. China
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2022
16.18.2.1. By Disease Type
16.18.2.2. By Phototherapy Type
16.18.2.3. By End User
16.19. Japan
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2022
16.19.2.1. By Disease Type
16.19.2.2. By Phototherapy Type
16.19.2.3. By End User
16.20. South Korea
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2022
16.20.2.1. By Disease Type
16.20.2.2. By Phototherapy Type
16.20.2.3. By End User
16.21. GCC Countries
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2022
16.21.2.1. By Disease Type
16.21.2.2. By Phototherapy Type
16.21.2.3. By End User
16.22. South Africa
16.22.1. Pricing Analysis
16.22.2. Market Share Analysis, 2022
16.22.2.1. By Disease Type
16.22.2.2. By Phototherapy Type
16.22.2.3. By End User
16.23. Israel
16.23.1. Pricing Analysis
16.23.2. Market Share Analysis, 2022
16.23.2.1. By Disease Type
16.23.2.2. By Phototherapy Type
16.23.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Disease Type
17.3.3. By Phototherapy Type
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Lifespan
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. UC Irvine Health
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. Buffalo Medical Group
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Blackrock Clinic Limited
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. The Private Phototherapy Clinic Ltd
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. National Skin Centre
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Massachusetts General Hospital
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Signify Holding
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. GE Healthcare
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. Natus Medical Incorporated
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Phototherapy Treatment Market
